PFM Health Sciences’s Arena Pharmaceuticals Inc ARNA Stock Holding History

PFM Health Sciences’s Portfolio ARNA Stock Details ARNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-345,523	Closed	-$23.6M	–	102
2021 Q2	$23.6M	Buy	+345,523	New	+$22.5M	0.74%	45
2020 Q3	–	Sell	-261,808	Closed	-$16.5M	–	100
2020 Q2	$16.5M	Sell	261,808 -487,409	-65%	-$26.8M	0.85%	45
2020 Q1	$31.5M	Sell	749,217 -321,399	-30%	-$14.7M	2.58%	16
2019 Q4	$48.6M	Sell	1,070,616 -1,200,920	-53%	-$56.8M	2.32%	16
2019 Q3	$104M	Buy	2,271,536 +443,158	+24%	+$24.9M	3.07%	7
2019 Q2	$107M	Sell	1,828,378 -1,426,852	-44%	-$73.7M	2.04%	11
2019 Q1	$146M	Buy	3,255,230 +240,558	+8%	+$11M	3.23%	3
2018 Q4	$117M	Buy	3,014,672 +285,117	+10%	+$11.2M	3.12%	4
2018 Q3	$126M	Buy	2,729,555 +1,532,664	+128%	+$62.1M	1.84%	10
2018 Q2	$52.2M	Buy	+1,196,891	New	+$51.4M	0.82%	45

Other funds holding ARNA

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

PAMS

Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

PFM Health Sciences's ARNA Position: Q3 2021 in Review

PFM Health Sciences sold out of Arena Pharmaceuticals Inc (ARNA) in Q3 2021, closing a stake of 345,523 shares — an estimated $23.6M sold.

PFM Health Sciences first reported a position in ARNA in Q2 2018 and held it in 10 quarters. The position peaked at $146M in Q1 2019. 235 funds tracked by Wall St. Rank hold ARNA as of Q3 2021.

PFM Health Sciences reported no remaining Arena Pharmaceuticals Inc position as of Q3 2021 after selling out during the quarter.
PFM Health Sciences sold 345,523 Arena Pharmaceuticals Inc shares in Q3 2021, an estimated $23.6M.
PFM Health Sciences first reported a position in Arena Pharmaceuticals Inc in Q2 2018 and held it in 10 quarters.
PFM Health Sciences's Arena Pharmaceuticals Inc position peaked at $146M in Q1 2019.
235 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q3 2021.

Based on PFM Health Sciences's 13F filing for Q3 2021, filed 15 Nov 2021.